Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established After Controlled Ovarian Stimulation in Clinical Trial 38825 for Org 36286 (Corifollitropin Alfa)
Phase of Trial: Phase III
Latest Information Update: 21 Apr 2017
At a glance
- Drugs Corifollitropin alfa (Primary)
- Indications Infertility
- Focus Adverse reactions; Registrational
- Sponsors Merck Sharp & Dohme; Organon; Schering-Plough
- 30 Jun 2012 Additional trial locations added as reported by European Clinical Trials Database.
- 19 Feb 2010 Actual end date (Dec 2009) added as reported by ClinicalTrials.gov.
- 19 Feb 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.